Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.
Type:
Grant
Filed:
July 28, 2023
Date of Patent:
February 20, 2024
Assignee:
Zenflow, Inc.
Inventors:
Marcel Song Sicotte, Austin Michael Bly, Ben Collett-Nye, Shreya Mehta
Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.
Type:
Grant
Filed:
November 18, 2020
Date of Patent:
February 6, 2024
Assignee:
ZENFLOW, INC.
Inventors:
Austin Michael Bly, Cesar Abalos Ico, Shreya Mehta, William Martin Belef, Samuel Allen Scaglione, Marcel Song Sicotte, Khoi Le
Abstract: Benign prosthetic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. Treatment options for BPH include medication, surgery (e.g., removal of enlarged prostate tissue), and minimally invasive procedures (e.g., needle ablation, electrovaporization, thermotherapy, and stent insertion). Minimally invasive procedure is typically the preferred choice if medication is ineffective. Accordingly, disclosed herein are system and method for treating BPH using improved implant and delivery device. Certain embodiments of the delivery device can include: a camming barrel having a first groove at the distal end of the camming barrel; a sheath, located within a lumen of the camming barrel, for storing the implantable device; and a first cam follower coupled to the sheath.
Type:
Grant
Filed:
February 17, 2021
Date of Patent:
November 14, 2023
Assignee:
ZENFLOW, INC.
Inventors:
Marcel Song Sicotte, Shreya Mehta, Austin Michael Bly, Ronald J. Jabba
Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.
Type:
Grant
Filed:
May 16, 2019
Date of Patent:
October 3, 2023
Assignee:
ZENFLOW, INC.
Inventors:
Austin Michael Bly, Marcel Song Sicotte, Shreya Mehta, William Martin Belef, Nicholas Damiano
Abstract: Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.
Type:
Grant
Filed:
June 6, 2019
Date of Patent:
August 24, 2021
Assignee:
ZENFLOW, INC.
Inventors:
Marcel Song Sicotte, Austin Michael Bly, Ben Collett-Nye, Shreya Mehta
Abstract: Benign prosthetic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. Treatment options for BPH include medication, surgery (e.g., removal of enlarged prostate tissue), and minimally invasive procedures (e.g., needle ablation, electrovaporization, thermotherapy, and stent insertion). Minimally invasive procedure is typically the preferred choice if medication is ineffective. Accordingly, disclosed herein are system and method for treating BPH using improved implant and delivery device. Certain embodiments of the delivery device can include: a camming barrel having a first groove at the distal end of the camming barrel; a sheath, located within a lumen of the camming barrel, for storing the implantable device; and a first cam follower coupled to the sheath.
Type:
Grant
Filed:
October 9, 2018
Date of Patent:
March 23, 2021
Assignee:
ZENFLOW, INC.
Inventors:
Marcel Song Sicotte, Shreya Mehta, Austin Michael Bly, Ronald J. Jabba